CLV Share Price Performance
AU$0.96
0.40 (72.97%)
25.0% undervalued intrinsic discount
AU$1.28
Fair Value
Price AU$0.96
AnalystConsensusTarget AU$1.28
Fair ValueAU$1.28
Share Pricen/a
New Narrative • Jul 15
Clover Corporation Limited Stock Price
- 1 Narratives written by author
- 0 Comments on narratives written by author
- 6 Fair Values set on narratives written by author
CLV Community Narratives
AN
Fair Value
·Fair Value AU$1.28 25.0% undervalued intrinsic discount
Expanded Omega Portfolio And Vertical Integration Will Support Long-Term Earnings Potential
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Expanded Omega Portfolio And Vertical Integration Will Support Long-Term Earnings Potential
Clover Corporation is turning a niche omega ingredient business into a broader menu of specialised products, aiming to win more customers across infant formula, everyday nutrition, and sports and seniors markets. The big question is whether its push into new products, distributors, and in-house supply can lift growth and reliability—or leave it stuck with slow customer approvals and inventory risk.Read more
AN
AU$1.28
25.0% undervalued intrinsic discount
Fair Value
Revenue
17.43% p.a.
Profit Margin
12.82%
Future PE
13.76x
Price in 2029
AU$1.57
Trending Discussion
No trending discussion available.
Recently Updated Narratives
AN
Expanded Omega Portfolio And Vertical Integration Will Support Long-Term Earnings Potential
Fair Value: AU$1.28 25.0% undervalued intrinsic discount
1 fair value setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Clover Corporation Limited Key Details
Last Reported Earnings
Jan 31, 2026
Next Reporting Earnings
Sep 23, 2026
- 0.054
- 34.25%
- 9.61%
- 0%
About CLV
- Founded
- 1988
- Employees
- 68
- CEO
- WebsiteView website
Clover Corporation Limited engages in the production, refining, and sale of natural oils and encapsulated powders in Australia, New Zealand, Asia, Europe, the Middle East, and the Americas. It supplies refined Omega 3 oils and various encapsulated ingredients for infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. The company offers Nu-Mega’s Driphorm microencapsulated powders, which enables the addition of Hi-DHA tuna and/or algal oils to products. Clover Corporation Limited was incorporated in 1988 and is headquartered in Altona North, Australia.
